Literature DB >> 1122933

A comparsion of the effects of prazosin and hydrallazine on blood pressure, heart rate and plasma renin activity in conscious renal hypertensive dogs.

R Massingham, M L Hayden.   

Abstract

Prazosin, a novel antihypertensive agent, and hydrallazine have been compared in renal hypertensive dogs. I.v. prazosin (0.1 mg/kg) produced greater falls in blood pressure than hydrallazine (1 mg/kg i.v.) but, in contrast to hydrallazine, did not cause any significant alteration in heart rate or plasma renin activity in these animals. When given orally, prazosin (0.1 mg/kg) produced falls in blood pressure equivalent to those observed with i.v. hydrallazine (1 mg/kg) again without significant tachycardia or plasma renin activation.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1122933     DOI: 10.1016/0014-2999(75)90213-7

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  17 in total

1.  Prazosin, a selective antagonist of post-synaptic alpha-adrenoceptors [proceedings].

Authors:  D Cambridge; M J Davey; R Massingham
Journal:  Br J Pharmacol       Date:  1977-03       Impact factor: 8.739

2.  Haemodynamic effects of dicentrine, a novel alpha 1-adrenoceptor antagonist: comparison with prazosin in spontaneously hypertensive and normotensive Wistar-Kyoto rats.

Authors:  S M Yu; S Y Hsu; F N Ko; C C Chen; Y L Huang; T F Huang; C M Teng
Journal:  Br J Pharmacol       Date:  1992-08       Impact factor: 8.739

Review 3.  Prazosin: a review of its pharmacological properties and therapeutic efficacy in hypertension.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1977-09       Impact factor: 9.546

4.  Pharmacological evidence that alpha1-and alpha2-adrenoceptors mediate vasoconstriction of carotid arteriovenous anastomoses in anaesthetized pigs.

Authors:  E W Willems; M Trion; P De Vries; J P Heiligers; C M Villalón; P R Saxena
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

5.  The influence of repeated administration of prazosin on its hypotensive effect and on renin release in conscious dogs. A comparison with urapidil.

Authors:  A Beck; O Kraupp; S Bacher; R Seitelberger; G Raberger
Journal:  Basic Res Cardiol       Date:  1984 Sep-Oct       Impact factor: 17.165

6.  Studies on the clinical pharmacology of prazosin. I: Cardiovascular, catecholamine and endocrine changes following a single dose.

Authors:  P C Rubin; T F Blaschke
Journal:  Br J Clin Pharmacol       Date:  1980-07       Impact factor: 4.335

7.  Canine external carotid vasoconstriction to methysergide, ergotamine and dihydroergotamine: role of 5-HT1B/1D receptors and alpha2-adrenoceptors.

Authors:  C M Villalón; P De Vries; G Rabelo; D Centurión; A Sánchez-López; P Saxena
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

8.  Prazosin depression of baroreflex function in hypertensive man.

Authors:  E H Sasso; D T O'Connor
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

9.  The effect of growth hormone releasing peptide-2 on upper gastrointestinal contractile activity and food intake in conscious dogs.

Authors:  Katsuyoshi Kudoh; Chikashi Shibata; Yuji Funayama; Kouhei Fukushima; Tatsuya Ueno; Keiichi Hayashi; Akio Inui; Cyril Y Bowers; Iwao Sasaki
Journal:  J Gastroenterol       Date:  2009-03-07       Impact factor: 7.527

Review 10.  Effect of antihypertensive drugs on the renin-angiotensin system.

Authors:  C I Johnston
Journal:  Drugs       Date:  1976       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.